Table 1 Khorana Risk Assessment Model
Patient characteristic | Risk Score |
|---|---|
1. Site of cancer | |
▪ Very high risk (stomach, pancreas) | 2 |
▪ High risk (Lung, Lymphoma, Gynecologic, bladder, testicular) | 1 |
2. Prechemotherapy platelet count 350 × 109/L or more | 1 |
3. Hemoglobin level less than 100 g/L or use of red cell growth factors | 1 |
4. Prechemotherapy leukocyte count more than 11 × 109 /L | 1 |
5. BMI: 35 kg/m2 or more | 1 |